article thumbnail

Wake Network Retains CRO Santé Cannabis to Conduct Clinical Trials in Psilocybin Therapies

Cannabis Law Report

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol. .

article thumbnail

Press Release: Global Wellness Signs Definitive Agreement with Cannvalate Australia

Cannabis Law Report

This acquisition is focused on becoming the first and only company solving the puzzle of chronic pain with MDMA-based medicines utilizing clinical trials for the purposes of novel drug development. The global chronic pain treatment market is predicted to progress at a CAGR of 6.5% 2014; 7: 115-124. billion in 2030.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

United States Minor Cannabinoids (CBG, CBC, CBN, THCV, CBGA) Markets Report 2021-2028 – ResearchAndMarkets.com

Cannabis Law Report

In addition, rising strategic initiatives by key players in the form of collaborations, clinical trials, and production are further contributing to increasing awareness and adoption of THCV products. Rising clinical trials is thus anticipated to boost the adoption and penetration of rare cannabis derivatives in the forthcoming years.

article thumbnail

8 Interesting Health Benefits of Cannabis That You Should Know

Cannabis Law Report

According to clinical trials, CBD decreases pro-inflammatory cytokines, inhibits T cell proliferation, causes T cell death, and inhibits immune cell migration and adhesion. CBD, typically in combination with THC, has been a helpful pain treatment for various chronic disease studies. Relaxes Body Muscles. Manages Weight.

article thumbnail

New Frontiers in the Law of Psychedelics

Cannabis Law Report

Not only are more and more jurisdictions decriminalizing the use of psychedelics for recreational purposes, but it appears that psychedelic substances are the new horizon for the treatment of severe psychological disorders and other ailments. Since May 2014, 41 states have enacted Right to Try laws. Id ; 21 CFR 312.1-10; 10; 312.80-88;

Law 105
article thumbnail

Best strains and terpenes for pain management

The Cannigma

Over 10% of US adults have suffered from some degree of daily pain for at least three months, so the need for improved treatment is clear. There have been a number of preclinical and clinical trials studying cannabis’ effects on pain. 12 Pinene had the ability to meditate chemical responses to inflammation in rodent trials.

Terpenes 111
article thumbnail

Announcement: Michael Mullette Joins MAPS PBC Senior Leadership as Chief Operating Officer

Cannabis Law Report

With Mike, MAPS PBC is taking another major step in building a world-class pharmaceutical organization capable of meeting the enormous need for novel treatments for PTSD and other mental health conditions. He brings to MAPS PBC a wealth of experience in drug development, expertise in drug commercialization, and a global perspective.

Therapy 52